/

Business

First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant Depression

First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant Depression

Beckley Psytech’s Phase IIa study will explore the safety, efficacy and pharmacokinetics of a single dose of BPL-003, in combination with psychological support, in patients with Treatment Resistant Depression (TRD).
Panacea Life Sciences Is Conducting Research for Production on the Most Famous Mushroom: Amanita MuscariaShutterstock: Kateryna Kon

Panacea Life Sciences Is Conducting Research for Production on the Most Famous Mushroom: Amanita Muscaria

,
Panacea Life Sciences is conducting research and formulation design for product development expansion in the fast-growing mushroom category. 
Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up Partnership

Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up Partnership

,
A start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic clinical trials.
Applications of VR and AR in Psychedelic-Assisted Therapy

Applications of AR and VR in Psychedelic-Assisted Therapy

,
The combined application of psychedelic-assisted psychotherapy and virtual, mixed, and augmented reality tools can create a unique set and setting that enhances the therapeutic experience and outcomes.
30 UNDER 30 WOMEN IN PSYCHEDELICS

30 Under 30 Women In Psychedelics

,
Psychedelic careers have boomed in the past few years. Paving the way for a new generation of psychedelic researchers, therapists, integration specialists, policy workers, communications experts, and so much more. Entering and supporting a field…
Beckley Psytech Begins Phase IIa Study of 5-MeO-DMT to Treat Alcohol Use Disorder

Beckley Psytech Begins Phase IIa Study of 5-MeO-DMT to Treat Alcohol Use Disorder

,
A Phase IIa clinical trial of 5-MeO-DMT for the treatment of alcohol use disorder (AUD) has begun this month.
Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBS

Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBS

,
Tryp completes their Phase 2a psilocybin for IBS clinical trial training for psychotherapists at Massachusetts General Hospital.
The Biggest Psychedelic News Stories This Week - March 10

The Biggest Psychedelic News Stories This Week – March 10

,
Health Canada's decision to deny a terminally ill Saskatoon man permission to continue psychedelic psilocybin therapy has drawn a lot of attention and criticism from psychedelic advocates.
BC company creates world's first ever Ayahuasca pill

Vancouver Company Creates World’s First Ever Ayahuasca Pill

,
Ayahuasca pills provide users with an easily accessible, safe and convenient way to explore spiritual realms like never before.

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.